CFH and Parkinson disease: It has also been found that increased concentrations of complement 3 and CFH in the cerebrospinal fluid (CSF) of Parkinson’s disease, Alzheimer’s disease, and multiple-system atrophy patients correlated with disease severity (Wang et al. 2011).